---
title: "Oncology Generic Medicines - Additions"
ocid: "ocds-h6vhtk-029adf"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029adf"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-029adf.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-029adf.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2021-06-22"
---

# Oncology Generic Medicines - Additions

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-h6vhtk-029adf

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029adf)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-029adf.json)

## Summary

The procurement process titled "Oncology Generic Medicines - Additions" is being conducted by The Common Services Agency, commonly known as NHS National Services Scotland (NSS), focusing on the supply of pharmaceutical products in the UK. This open procedure is currently at the active tender stage and will conclude on 13 April 2021, with a potential contract duration of nineteen months and the possibility of a twenty-four month extension. The value of this framework agreement is estimated at £17,077,727. Delivery locations will cover entities governed by the National Health Service (Scotland) Act 1978 and Integrated Joint Boards established under the Public Bodies (Joint Working) Scotland Act 2014.

This tender presents significant opportunities for businesses involved in the pharmaceutical sector, particularly those with expertise in oncology medicines. Firms capable of supplying specialty medicines, large quantities, and demonstrating compliance with quality standards are well-suited to compete for this contract. Companies that can meet stringent criteria, including valid UK Marketing Authorisation and quality certifications, may find a competitive edge in securing contracts within this considerable framework agreement.

## Notice

Supply of oncology generic medicines to NHS Scotland

### Lot Information

Everolimus Tablets

Supply of everolimus tablets to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework to three (3) Framework Participants.

Renewal: This framework includes the option to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Dasatinib Tablets

Supply of dasatinib tablets to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cabazitaxel, Fulvestrant and Vinorelbine

Supply of cabazitaxel, fulvestrant and vinorelbine to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line.

Renewal: This framework includes the option to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Pemetrexed Solution for Infusion

Supply of pemetrexed solution for infusion to NHS Scotland. The Authority has awarded this Lot as a single supplier framework.

Renewal: This framework includes the option to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Pemetrexed Powder for Solution for Infusion

Supply of pemetrexed powder for solution for infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Paclitaxel Albumin Powder for Suspension for Infusion

Supply of paclitaxel albumin powder for suspension for infusion to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/014174-2021 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 22 Jun 2021 |
| Submission deadline | 13 Apr 2021 |
| Future notice date | Not specified |
| Award date | 8 Jun 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £17,077,727 |
| Lots value | £19,609,169 |
| Awards value | Not specified |
| Contracts value | £2,703,327 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Active, Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 8 |
| Supplier names | ACCORD HEALTHCARE; CELGENE; DR REDDY'S LABORATORIES (UK; NOVARTIS PHARMACEUTICALS; PIERRE FABRE; TEVA; TILLOMED LABORATORIES; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 22 Jun 2021 at 10:44 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/014174-2021
- 11 Mar 2021 at 16:40 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/004974-2021

## Notice URLs

- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
- https://www.publictendersscotland.publiccontractsscotland.gov.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029adf. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-029adf.json.
